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Abstract
Solid pseudopapillary neoplasm of pancreas (SPN) is a rare entity; therefore proper diagnosis, evaluation and formulation
of treatment protocols is difficult. A total of 14 cases were diagnosed and treated at our institute over a 10-year period
(1992/2002). A retrospective study of all these cases was performed with respect to age group most frequently affected, sex
ratio, common presenting symptoms and signs, investigative protocols, pathological features, treatment offered, outcome
and prognosis. All the 14 patients were females, with a median age of 20 years (range 13/45 years). The commonest
presenting symptom was abdominal pain. All these patients underwent surgical exploration; 13 patients underwent
resection of the tumour. The average length of postoperative hospital stay was 10.3 days. Significant postoperative morbidity
was seen in only one case. There was no postoperative mortality. All these patients who underwent resection were
disease-free on follow-up ranging from 6 to 96 months (median 36 months).
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Introduction
Solid pseudopapillary neoplasm of pancreas (SPN) is
a rare entity. It is almost exclusively seen in females
and occurs in the second or third decades of life [1/
3]. Due to the paucity of the number of cases seen, the
natural history of the disease is not fully understood.
There has been a steady increase in the number of
diagnosed cases of SPN recently, with more than two-
thirds of the total cases described in the last 10 years
[4]. This study was undertaken to examine the
clinico-pathological characteristics of the disease and
to evaluate the outcome of surgical intervention in a
tertiary referral cancer centre.
Patients and methods
A retrospective analysis of all patients diagnosed and
treated for SPN in our hospital over the past 10 years
(1992/2002) was carried out. The clinico-pathologi-
cal, radiological, operative and survival data were
obtained and analysed. In all, 14 patients were
identified.
A CT scan of the abdomen was performed in all the
patients and the findings revealed a mass in the
pancreas. Pre-operative fine needle aspiration cytol-
ogy (FNAC) was performed in 4/14 patients.
All the patients who underwent resection were
followed up every 6 months. The investigations
performed included routine blood investigations,
chest X-ray, CA-19-9 level and either an ultrasound
or a CT scan of the abdomen.
Results
All the patients were females in the age group of
13/45 years (median 20 years). Ten patients pre-
sented with a dull aching pain in the abdomen. Two
presented with a painless abdominal mass (14%) in
the epigastric region. Two patients had non-specific
abdominal symptoms for which they had been investi-
gated (14%). In five patients the tumour was located
in the pancreatic head (36%), in two it was located in
the body (14%), and in the remaining seven patients it
occurred in the tail (50%). The tumour size ranged
from 3 to 18 cm (average 6.8 cm). Four patients had
undergone a preoperative FNAC: in three patients the
FNAC correctly diagnosed SPN while one was
reported as non-Hodgkin’s lymphoma (however, the
final HPR revealed the tumour to be SPN).
All the 14 patients were taken up for surgery. Of
these, 13 patients underwent resection of the tumour.
In one patient the tumour was infiltrating the inferior
vena cava as well as the colon, and therefore no
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resection was performed. Six patients underwent
distal pancreatectomy with splenectomy, two under-
went a pylorus-preserving pancreatoduodenectomy,
and two patients required right hemicolectomy along
with a Whipple resection. Two required subtotal distal
pancreatectomy with splenectomy. One underwent
spleen-preserving distal pancreatectomy. None of
these patients had distant metastasis.
One patient suffered from a major morbidity. This
patient had undergone a subtotal-distal pancreatect-
omy with splenectomy, and had suffered an inad-
vertent injury to the intra-pancreatic portion of the
common bile duct (CBD) during the excision. This
patient required a t-tube placement in the duct. Post-
operatively, a stent was placed endoscopically to
facilitate the removal of the t-tube. The stent was
removed 3 months later with no further problems.
This was the only complication in the 13 patients who
underwent resection.
The average postoperative hospital stay was 10.3
days. There was no postoperative mortality. All
13 patients were free of disease in a median follow-
up period of 36 months (range 6/96 months).
Discussion
SPN is predominantly encountered in young, female
patients (first three decades of life), but has also been
reported in males and in children [1,3]. In our series,
all the patients were females with a median age of
20 years.
These tumours may be discovered by chance during
diagnostic imaging procedures or may be suspected in
the presence of an asymptomatic palpable mass in
young women. In our series, 10 patients presented
with dull aching abdominal pain, while 2 patients
presented with an abdominal mass.
Depending on the tumour position (head, body or
tail of the pancreas), the differential diagnosis includes
adrenal mass, pancreatic endocrine tumour, liver cyst
or tumour, or a pseudocyst [5].
CT scan (Figure 1), ultrasonography (US) and
endosonography (EUS) have been used with variable
success in diagnosing SPN. CT scan and EUS are
more sensitive and specific and have shown more
accuracy in diagnosing SPN [6,7]. Magntetic reso-
nance imaging (MRI) can be diagnostic. Typically, a
large, well-defined, encapsulated lesion with hetero-
geneous high or low signal intensity on T1-weighted,
heterogeneous high signal intensity on T2-weighted,
and early peripheral heterogeneous enhancement with
progressive fill-in is found on gadolinium-enhanced
dynamic MRI. These features help differentiate this
rare tumour from other pancreatic neoplasms [8]. In
our series, we relied on CT imaging for the pre-
operative work-up.
FNAC has been used for the preoperative cytolo-
gical diagnosis of SPN [6,9]. The cytology specimen
is usually highly cellular and is characterized by
the presence of epitheloid cells that present singly or
in aggregates containing fibrovascular cores. No
evidence of pleomorphism or mitotic activity is seen
in the cells. The most conclusive criterion for identi-
fication of SPN is the pseudopapillary arrangement
with bland appearing tumour cells. EUS-guided
FNAC has been reported, and this can help in
correctly diagnosing SPN pre-operatively [10]. In
the current series, 4/14 patients had a pre-operative
percutaneous US-guided FNAC, and the diagnosis
of SPN was made correctly in 3 patients. It is not
necessary to have a tissue diagnosis pre-operatively,
and surgery can be advised on the basis of radio-
logical imaging.
The histogenesis of these tumours is unknown but
they possibly originate from the primordial cells and
lack definite endocrine and exocrine differentiation.
On gross examination, SPN is a well encapsulated
tumor. On cut section it shows solid and cystic
areas with necrotic and haemorrhagic patches. Some
tumours also demonstrate firm, fibrotic regions within
the tumour. On microscopy, there are solid areas
composed of polygonal epithelioid cells with inter-
vening stroma. There is evidence of cellular degenera-
tion. Aggregates of foamy histiocytes, cholesterol
clefts and cytoplasmic vacuolization can be seen.
Despite being an encapsulated tumour, the micro-
scopic interface between tumour and adjacent normal
pancreas does show an infiltrative growth pattern
[1,2,4,6,11/13] (Figure 2).
Immunohistochemical studies have shown that SPN
is reactive for vimentin, antitrypsin, cytokeratin, S-
100 protein and neuron-specific enolase. Flow cyto-
metry shows aneuploidy. C-Ha-as oncogene presum-
ably is linked to the development of the tumour. No
pathologic factor is of proven prognostic importance
[11/13]. Laboratory values are not contributory,
although a few cases do show raised levels of CA19-9.
SPN is considered to be a tumour of low-grade
malignant potential [14]. The logical conclusion is
that complete surgical excision is the best option for
patients who have SPN. Thus surgery should always
be attempted in a suspected case of SPN even if it
implies that major resections (like pancreaticoduode-
Figure 1. CT scan image of a SPN in the body and tail of pancreas.
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